Contact No 175 - October December 2001
Disaster Preparedness Training Programme
Disaster Preparedness Training Programme
El asesoramiento sobre lactancia materna es una interacción bidireccional entre un/a asesor/a con formación en lactancia
materna y una o varias mujeres embarazadas, madres u otras personas cuidadoras de niños/as menores de dos años
(normalmente). El proceso consiste en escuchar inquietudes, ab...ordar distintas cuestiones, instruir en torno a la lactancia
materna y observar y acompañar el proceso normal de lactancia materna y las dificultades que puede plantear. El propósito
del asesoramiento sobre lactancia materna es empoderar a las mujeres para que la practiquen y fortalecer las prácticas de
cuidados receptivos, respetando en todo momento su situación personal y su voluntadx
more
This manual has been developed as a self-help tool for caregivers of people with dementia. Each module is divided into lessons
Este manual ha sido desarrollado como una herramienta de auto-ayuda para cuidadores de personas con demencia. Cada módulo está dividido en lecciones
individuales. Cada lección está estructurada de la misma forma:
1. Al inicio se encuentra un resumen de porqué esa lección es importante,
2. ...Cómo la lección te ayudará como cuidador y
3. Lo que aprenderás en ella.
Cada lección contiene una mezcla de información resumida, ejemplos descriptivos, preguntas de respuesta múltiple y actividades para practicar lo aprendido. Así
podrás encontrar ejercicios y actividades individuales que te permitirán comprobar tu comprensión y reflexionar sobre tu aprendizaje de forma práctica.
more
COVID-19 Situation Update OPS/WHO Argentina: 10 February 2022
Situation report generated by the OPS/WHO representation in Argentina
Background: Healthcare workers’ mental health was affected by SARS-CoV-2 pandemic.
Aim: To evaluate healthcare workers’ mental health and its associated factors during the pandemic in Chile. Material and Methods: An online self-reported questionnaire was designed including the Goldberg Healt...h Questionnaire, the Patient Health
Questionnaire, (PHQ-9), and the Columbia-Suicide Severity Rating Scale among other questions. It was sent to 28,038 healthcare workers.
Results: The questionnaire was answered by 1,934 participants, with a median age of 38 years (74% women). Seventy five percent were professionals, and 48% worked at a hospital. Fifty nine percent of respondents had a risk of having a mental health disorder, and 73% had depressive symptoms. Significant associations were found with sex, workplace, and some of the relevant experiences during the pandemic. Fifty one
percent reported the need for mental health support, and 38% of them received it.
Conclusions: There is a high percentage of health workers with symptoms of psychological distress, depression, and suicidal ideas. The gender approach is essential to understand the important differences found. Many health workers who required mental health care did not seek or received it.
more
Crecer bien en un mundo en transformación
En este documento se ofrece, en un formato de fácil consulta, el panorama general de las cuestiones relativas a la salud y los derechos sexuales y reproductivos que pueden afectar a los derechos humanos, la salud y el bienestar de los adolescentes (de edades comprendidas entre los 10 y los 19 años...) y las directrices pertinentes de la Organización Mundial de la Salud (OMS) para abordar dichas cuestiones. Este documento permite acceder al amplio conjunto de directrices de la OMS al respecto y constituye un útil recurso para la labor de promoción, formulación de políticas, investigación y diseño de programas y proyectos. Tiene por finalidad apoyar la aplicación de la Estrategia Mundial para la Salud de la Mujer, el Niño y el Adolescente 2016-2030 (1) y está armonizado con las medidas mundiales aceleradas en favor de la salud de los adolescentes (AA HA!) de la OMS y el marco operativo de la OMS sobre salud sexual y su relación con la salud reproductiva (2, 3).
more
WHO Medical Devices Donations - SPANISH Version - Las tecnologías sanitarias son fundamentales en un sistema de salud operativo. Los dispositivos médicos, en concreto, son cruciales para la prevención, el diagnóstico, el tratamiento y la rehabilitación de enfermedades. Estos documentos están d...irigidos a ingenieros biomédicos, administradores sanitarios,
donantes, organizaciones no gubernamentales e instituciones científicas implicados en la tecnología sanitaria a nivel de distrito, nacional, regional o mundial.
more
At the end of 2023, WHO convened our first-ever annual WHO Stakeholder Review Conference for Prevention and Response to Sexual Misconduct. Aimed at joint learning and frank discussion on challenges faced in the achieving zero tolerance for all forms of sexual misconduct by aid workers, the Conferenc...e brought together Member States, Civil Society Organizations, United Nations Agencies and Programmes, academia and media joined by WHO personnel. A set of recommendations to support all agencies are documented in the Conference Report. In addition, WHO’s Director-General hosted a social engagement segment on the evening of Day 1 to further underscore the centrality of a victim and survivor-centred approach, to celebrate progress however small, and to reaffirm commitment and renew energy for the journey ahead. The Conference took place on 30 November and 1 December 2023 in Geneva, Switzerland
more
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-severe COVID-19
The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19.
The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients.
This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines:
**High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%.
**Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%.
Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk.
Review of COVID-19 treatments for people with non-severe COVID-19
WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022.
If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead.
WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission.
For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol.
WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials.
The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials.
more
A Global Inventory of Alternative Medical Waste Treatment Technologies